The fraction of lung cancer incidence attributable to fine particulate air pollution in France: Impact of spatial resolution of air pollution models by Kulhanova, Ivana et al.
HAL Id: hal-02089354
https://hal.archives-ouvertes.fr/hal-02089354
Submitted on 3 Apr 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
The fraction of lung cancer incidence attributable to fine
particulate air pollution in France: Impact of spatial
resolution of air pollution models
Ivana Kulhanova, Xavier Morelli, Alain Le Tertre, Dana Loomis, Barbara
Charbotel, Sylvia Medina, Jean-Nicolas Ormsby, Johanna Lepeule, Rémy
Slama, Isabelle Soejormataram
To cite this version:
Ivana Kulhanova, Xavier Morelli, Alain Le Tertre, Dana Loomis, Barbara Charbotel, et al.. The
fraction of lung cancer incidence attributable to fine particulate air pollution in France: Impact of
spatial resolution of air pollution models. Environment International, Elsevier, 2018, 121 (Part 2),
pp.1079-1086. ￿10.1016/j.envint.2018.09.055￿. ￿hal-02089354￿
Contents lists available at ScienceDirect
Environment International
journal homepage: www.elsevier.com/locate/envint
The fraction of lung cancer incidence attributable to fine particulate air
pollution in France: Impact of spatial resolution of air pollution models
Ivana Kulhánováa,⁎,1, Xavier Morellia,b,1, Alain Le Tertrec, Dana Loomisd, Barbara Charbotele,f,
Sylvia Medinac, Jean-Nicolas Ormsbyg, Johanna Lepeuleh, Rémy Slamah,
Isabelle Soerjomatarama
a Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
bDepartment of Cancer and Environment, Centre Léon Bérard, Lyon, France
c Santé publique France, Paris, France
dMonographs Section, International Agency for Research on Cancer, Lyon, France
eUniversité de Lyon, Université Claude Bernard Lyon 1, IFSTTAR, UMRESTTE, UMR_T9405, Lyon, France
f Service des maladies professionnelles, Hospices Civils de Lyon, Lyon, France
g French Agency for Food, Environmental and Occupational Health & Safety, Maisons-Alfort, France
h Inserm, CNRS, University Grenoble-Alpes, IAB (Institute for Advanced Biosciences), Team of Environmental Epidemiology, Grenoble, France
A R T I C L E I N F O
Handling Editor: X Querol
Keywords:
Air pollution
Lung cancer
Population attributable fraction
France
A B S T R A C T
Outdoor air pollution is a leading environmental cause of death and cancer incidence in humans. We aimed to
estimate the fraction of lung cancer incidence attributable to fine particulate matter (PM2.5) exposure in France,
and secondarily to illustrate the influence of the input data and the spatial resolution of information on air
pollution levels on this estimate. The population attributable fraction (PAF) was estimated using a nationwide
spatially refined chemistry-transport model with a 2-km spatial resolution, neighbourhood-scale population
density data, and a relative risk from a published meta-analysis. We used the WHO guideline value for PM2.5
exposure (10 μg/m3) as reference. Sensitivity analyses consisted in attributing the nation-wide median exposure
to all areas and using alternative input data such as reference of PM2.5 exposure level and relative risk.
Population-weighted median PM2.5 level in 2005 was 13.8 μg/m3; 87% of the population was exposed above the
guideline value. The burden of lung cancer attributable to PM2.5 exposure corresponded to 1466 cases, or 3.6%
of all cases diagnosed in 2015. Sensitivity analyses showed that the use of a national median of PM2.5 exposure
would have led to an underestimation of the PAF by 11% (population-weighted median) and by 72% (median of
raw concentration), suggesting that our estimates would have been higher with even more finely spatially-
resolved models. When the PM2.5 reference level was replaced by the 5th percentile of country-scale exposure
(4.9 μg/m3), PAF increased to 7.6%. Other sensitivity analyses resulted in even higher PAFs. Improvements in air
pollution are crucial for quantitative health impacts assessment studies. Actions to reduce PM2.5 levels could
substantially reduce the burden of lung cancer in France.
1. Introduction
Outdoor air pollution is a leading environmental cause of death and
is related to increased deaths from cardiovascular and respiratory dis-
eases (WHO Regional Office for Europe, 2013) as well as to the in-
cidence of numerous diseases. In 2010, Lelieveld and colleagues re-
ported that about 3.15 million deaths worldwide were attributable to
atmospheric fine particulate matter (PM2.5) (Lelieveld et al., 2015),
which represented about 6% of total mortality worldwide. A recent
Global Burden of Disease (GBD) study estimated that 4.2 million deaths
(or 7.5% of total global mortality) in 2015 were attributable to ambient
air pollution (GBD 2015 Risk Factors Collaborators, 2016). These re-
sults took into account only outdoor PM2.5 levels, household PM2.5 le-
vels from biomass burning were excluded. In France, PM2.5 were esti-
mated to be responsible for 9% of the total mortality (Pascal et al.,
2016). Regarding cancer, a group of experts convened by the Interna-
tional Agency for Research on Cancer (IARC) concluded that PM2.5 in
outdoor air is carcinogenic to humans (IARC Group 1), in particular for
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lung cancer (Loomis et al., 2013). In France, only estimates at the urban
area level are available, restricted to the Grenoble area (about 0.7% of
the total population in France) assessing that 6.8% of lung cancer cases
in this area were attributable to PM2.5 (Morelli et al., 2016).
Technological development has markedly advanced exposure as-
sessment to ambient air pollution. The majority of early etiologic stu-
dies on PM2.5 health effects have utilised data from air quality mon-
itoring networks (Ballester et al., 1996; Carugno et al., 2016; Fattore
et al., 2011; Filleul et al., 2005; Künzli et al., 2000; Medina et al., 2004),
which generally have a poor spatial resolution, with an increasing
number of studies relying on satellite imagery (Evans et al., 2013; Lim
et al., 2012) or chemical transport models (Anenberg et al., 2010).
When it comes to quantitative health impact assessment (HIA) studies,
background monitoring stations are generally used to assess exposure
(Pascal et al., 2013). However, recent HIA studies increasingly consider
air pollution models, some of which with high spatial resolution (Orru
et al., 2009; Pascal et al., 2016). A study in two French urban areas
suggested that assessing exposures from background monitoring sta-
tions may underestimate attributable risk of death by 10 to 20%,
compared to fine-scale models with spatial resolutions taking into ac-
count street-scale variations in the pollutants concentration (Morelli
et al., 2016). In France, such fine-scale models are available for small
geographical units such as the urban area (Bentayeb et al., 2014).
Here, we aimed to estimate the proportion and the number of new
lung cancer cases in France in 2015 attributable to exposure to PM2.5. A
secondary aim was to study the impact of the spatial resolution of PM2.5
exposure model and of information on population density. We also
tested the impact of changing the reference level and the relative risk
estimates (dose-response function) used. While outdoor air pollution is
a complex mixture containing various known carcinogens, PM2.5 was
chosen as an indicator of exposure as it is a prominent component of the
mixture, with proven long-term effects (WHO Regional Office for
Europe, 2013).
2. Materials and methods
2.1. Study design and area
The burden of lung cancer attributable to PM2.5 was calculated
using the population attributable fraction (PAF) based on Comparative
Risk Assessment method (Cohen et al., 2005; Ezzati et al., 2002). This
methodology is based on combining exposure to air pollution and its
distribution in the population with exposure-risk estimates at each level
of exposure (World Health Organization, 2016). This study design is
similar to HIA (1999). The study area was metropolitan France. We
assumed a latency time between exposure to PM2.5 and lung cancer
incidence of 10 years; as such the number of lung cancer cases attri-
butable to exposure to PM2.5 in the year 2015 was based on PM2.5
concentrations in 2005 (Yanagi et al., 2012). Information on population
density by neighbourhood was obtained for the year 2006 (the closest
to 2005 with data available by neighbourhood, or IRIS, a geographical
census unit generally consisting of 2000 persons) from the National
Institute of Statistics and Economic Studies (INSEE) (INSEE, n.d.). The
study population and the lung cancer incidence considered in this study
were restricted to adults at age of 30 years and above.
2.2. Air pollution exposure
Air pollution exposure (annual mean concentration of PM2.5) was
estimated from Gazel-Air model. This model is a nationwide air quality
model which provides annual mean concentration of PM2.5 on a
2×2 km grid in metropolitan France from 1989 to 2008. It was de-
veloped based on the CHIMERE chemistry-transport model, mesh re-
finement and data assimilation with geostatistical analyses (Bentayeb
et al., 2014). Emission data were derived from the European Monitoring
and Evaluation Program emission cadastre consisting of gridded annual
national emissions at 50 km resolution on the European scale. The
CHIMERE model was used to map PM2.5 concentrations at 10 km re-
solution in France. Finally, mesh refinement was performed to improve
the spatial distribution of PM2.5 concentrations at 2 km resolution
(Bentayeb et al., 2014). The modelling strategy has been described in
more details elsewhere (Bentayeb et al., 2014; Bentayeb et al., 2015). A
geographic information system (GIS) was used to combine the Gazel-Air
model with the population distribution by neighbourhood in order to
obtain a population-weighted PM2.5 exposure. The spatial distribution
of PM2.5 concentrations and the population density are illustrated in
Fig. 1.
Fig. 1. PM2.5 concentrations estimated by the Gazel-Air model (yearly averages in μg/m3; 2 km spatial resolution) in 2005 in metropolitan France (A) and population
density by neighbourhood (number of inhabitants/km2) in 2006 (B).
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2.3. Health outcome
Lung cancer incidence (ICD-10: C33–C34) was obtained from the
French network of cancer registries (FRANCIM) for 2013. To estimate
the number of lung cancer cases in 2015, we applied the 2013 age- and
sex-specific lung cancer incidence rates to the 2015 population. In
France, population-based cancer registries for adult population provide
incidence data for only 20% of the population (Santé publique France
2010), while lung cancer mortality is available for the entire country at
the municipality level. Assuming similarity between lung cancer mor-
tality and incidence due to high case-fatality for lung cancer (Alberg
et al., 2013), we used mortality data to estimate the fraction of lung
cancer attributable to PM2.5 excess exposure. Lung cancer deaths (ICD-
10: C34) by municipality were obtained from the Epidemiology Centre
on Medical Causes of Death of the National Institute of Health and
Medical Research (CépiDc, INSERM) for the years 2011–2013. How-
ever, lung cancer deaths were not disclosed for municipalities where a
recorded total number of deaths was lower than 5 between 2011 and
2013 due to confidentiality. These missing deaths accounted for ap-
proximately 3% (or 2769 deaths) of the total lung cancer deaths re-
corded in France.
We redistributed these missing lung cancer deaths using the fol-
lowing imputation method. First, we calculated the expected number of
lung cancer deaths in each municipality with missing information by
multiplying the population size of the municipality with the national
lung cancer mortality rate (48.1 per 100,000) reported for the year
2012 (Inserm/CépiDc, n.d.). We chose the year 2012 as the mid-year of
the period 2011–2013 of the mortality data. Then, we computed a
correction factor to restrict the number of the imputed lung cancer
deaths to 2769. This correction factor consisted of a ratio calculated in
the municipalities with missing information by dividing the total
number of missing lung cancer deaths by the total number of expected
lung cancer deaths. Finally, the expected number of lung cancer deaths
in municipalities with<5 deaths was weighted by the correction factor
to account for the missing 3% of lung cancer deaths (formula 1).
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where D is the total number of missing lung cancer deaths (2769), Ni is
the population size in each municipality i, MRLC is the lung cancer
mortality rate (48.1 per 100,000) reported in France for the year 2012,
and n is the number of municipalities with missing information. About
11,400 (or 31% of total) municipalities were imputed due to missing
information on lung cancer deaths. Attributing a homogeneous rate is
expected to reduce the variance of our final estimate and thus artifi-
cially reduce the confidence intervals.
2.4. Risk characterization
To estimate the proportion of lung cancer incidence attributable to
PM2.5 in France, we first calculated the number (AN) of lung cancer
deaths attributable to past excess exposure to PM2.5 in each neigh-
bourhood i according to the formula (2).
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where ni is the population size in neighbourhood i, D and N are the
number of lung cancer deaths and population in the smallest geo-
graphical unit available (IRIS), RR is the relative risk of lung cancer
associated with a 10 μg/m3 increases in exposure to PM2.5, Xi is the
PM2.5 concentration observed in the neighbourhood i, Xref is the re-
ference level chosen for PM2.5. When a neighbourhood was spatially
located across two (or more) grid cells of the Gazel-Air model, its
population was proportionally distributed to the corresponding grid
cells by applying a ratio based on the areas of the different neigh-
bourhoods sections.
The current World Health Organization (WHO) air quality guideline
– an annual mean concentration of 10 μg/m3 – was chosen as the re-
ference level of exposure to PM2.5 (World Health Organization, 2005).
This guideline represents the lowest level at which total, cardio-
pulmonary and lung cancer mortality have been demonstrated to in-
crease with more than 95% confidence in response to long-term ex-
posure to PM2.5 according to a study of the American Cancer Society
(Pope et al., 2002; World Health Organization, 2005). However, there is
no evidence of a threshold in the relation between PM2.5 exposure and
lung cancer incidence, which is why we also used an alternative re-
ference value in a sensitivity analysis (Pascal et al., 2016). Regarding
the relative risk (RR) of lung cancer associated with PM2.5 exposure, we
used the one from a meta-analysis by Hamra et al. (2014), which is
equal to 1.09 (95% confidence interval, CI: 1.04–1.14) for each 10 μg/
m3 increase in PM2.5 exposure. It is assumed to be the same for both
sexes. The meta-analysis from which the RR was derived included 14
studies of lung cancer mortality and incidence from Europe, North
America, China and Japan. All studies were adjusted for sex and age.
More than two thirds of studies were additionally adjusted for smoking
and socioeconomic status (Hamra et al., 2014).
Then, the PAF of lung cancer deaths related to excess exposure to
PM2.5 (i.e., above the reference level) was computed by summing
neighbourhood-specific PM2.5 attributable deaths and dividing them by
the total number of lung cancer deaths in the country for the same
period = ∑
=
PAF AN D/
i
n
i
1
. Finally, the PAF was multiplied by the esti-
mated lung cancer incidence in 2015 to derive the number of new lung
cancer cases in 2015 attributable to PM2.5 exposure in France. The re-
sults based on this analysis refer to the “main model”. The 95% con-
fidence intervals of the PAF were based on the variability of the RR
from the meta-analyses. All analytical steps necessary for the calcula-
tions are illustrated in Fig. S1 (Online supplementary material).
2.5. Sensitivity analyses
In addition to the main model, the impact of PM2.5 on lung cancer
incidence was assessed using five alternative hypotheses (H1–H5). In
the first hypothesis (H1), we estimated the number of lung cancer cases
attributable to PM2.5 assuming homogeneous population-weighted
PM2.5 exposure at the department (H1a) and country levels (H1b), i.e.
the same value of the PM2.5 exposure for each geographical unit ob-
served. The homogeneous values corresponded to the median PM2.5
exposure in each department or in the country. This allowed testing the
sensitivity of our estimate to the spatial resolution of the PM2.5 con-
centrations. In a second sensitivity analysis (H2), we assumed homo-
geneous raw value of the PM2.5 concentration at department (H2a) or
country level (H2b) testing the impact of population density.
The PM2.5 reference level and the concentration-response function
are central parameters of the estimation of the number of attributable
lung cancer cases. The third (H3) and fourth (H4) hypotheses assumed
an alternative reference level of PM2.5 and an alternative RR, respec-
tively. The reference level of PM2.5 in H3 was set to 4.9 μg/m3 and
corresponded to the 5th percentile of the PM2.5 annual concentrations
in rural areas in France observed in a recent study based on the same
exposure model (Pascal et al., 2016).
The RR applied in H4 was equal to 1.18 (95% CI: 0.96–1.46) per
5 μg/m3 increase in PM2.5, corresponding to 1.40 (95% CI: 0.92–2.13)
for a 10 μg/m3 increase in PM2.5. It was obtained from a meta-analysis
from ESCAPE project including 14 cohorts from eight European coun-
tries (Sweden, Norway, Denmark, the Netherlands, UK, Austria, Italy,
and Greece) (Raaschou-Nielsen et al., 2013). The estimate of the meta-
analysis was adjusted for age, sex, calendar time, smoking status,
smoking intensity, square of smoking intensity, smoking duration, time
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since quitting smoking, environmental tobacco smoke, occupation, fruit
intake, marital status, educational level, employment status, and area-
level socioeconomic status.
The fifth hypothesis (H5) was a combination of H3 and H4. The
hypotheses H3, H4, and H5 were applied to the main model, and to the
models at the department and country level. Data management and
analyses were performed in Stata version 13.0. QGIS software version
2.8 was used for analysing spatial data and cartography.
3. Results
3.1. Fine particulate matter exposure
The exposure to PM2.5 was assessed for 38.3 million inhabitants
aged 30 years and above and living in a total of 36,250 municipalities,
or 49,800 neighbourhoods. Fig. 2 describes the distribution of the po-
pulation-weighted exposure to PM2.5 in 2005. The 5th, 50th and 95th
percentiles of the population-weighted PM2.5 levels in France were 8.2,
13.8, 21.8 μg/m3, respectively. The population-weighted annual
average exposure was 14.4 μg/m3. Approximately 87% of the study
population was exposed above the yearly average WHO guideline value
of 10 μg/m3, while 99% was above the 4.9 μg/m3 value.
3.2. Lung cancer cases attributable to PM2.5 under the main hypotheses
The total number of lung cancer cases in subjects aged 30 or more
was estimated to be 40,451 (29,098 in men; 72% of total) in France in
2015. The estimated fraction of lung cancer cases attributable to PM2.5
in France in 2015 based on the main model was 3.6% of lung cancer
incidence, corresponding to 1466 cases (Table 1).
3.3. Sensitivity analyses
The sensitivity analyses are depicted in Table 1. Under hypothesis
H1, which assumed spatially homogeneous PM2.5 exposure at various
administrative scales, compared to the main model, the fraction and the
number of attributable lung cancer cases differed in relative value by
about 0.4% (overestimation under H1, when PM2.5 level was assumed
homogeneous within each department) and -11% (underestimation,
assuming homogeneity of PM2.5 level at the country level). Population
density information (H2) had a larger impact on estimates, with an
underestimation of the number of attributable cases by 34% at the
department level and 72% at the country level if raw PM2.5 con-
centration was applied for the calculations.
The PAF and the number of attributable lung cancer cases were
estimated to be 7.6% and 3065 cases, respectively, if the reference level
for PM2.5 was changed to 4.9 μg/m3 (H3). If the alternative RR of 1.40
per 10 μg/m3 increase in PM2.5 was used (H4), then the PAF and the
number of attributable lung cancer cases were estimated to be 12.9%
and 5232 cases, respectively. Under the assumption of combining the
alternative reference level of PM2.5 with the alternative RR (H5), the
PAF and the number of attributable lung cancer cases were even higher,
reaching 26.0% (or 10,510 cases).
4. Discussion
4.1. Summary of main findings
This nation-wide study indicates that the proportion of lung cancer
cases in France in 2015 attributable to PM2.5 exposure could be be-
tween 1% (416 cases) and 26.5% (10,733 cases), depending on the
spatial resolution PM2.5 exposure and on the assumptions made re-
garding the dose-response function and the reference level of PM2.5.
Based on the main model estimates, about 1500 lung cancer cases could
be attributable to PM2.5 exposure, representing approximately 4% of all
lung cancer cases in France in 2015. Whereas decreasing the spatial
distribution of PM2.5 exposure underestimated the number of attribu-
table lung cancer cases by 11%, the spatial resolution of information on
population density proved to be of high importance to obtain reliable
estimates. Indeed, the PAF and the number of attributable lung cancer
cases were underestimated by about 34% (department level) and 72%
(country level) when population density distribution was neglected in
terms of PM2.5 levels. Additionally, we confirmed that the PAF estimate
was highly sensitive to the choice of the concentration-response func-
tion and the reference level of PM2.5.
4.2. Underlying assumptions and entry parameters
This study has several limitations. The PM2.5 concentration was
assessed based on the Gazel-Air model (Bentayeb et al., 2014). This
model is derived using the CHIMERE chemistry-transport model, mesh
refinement and data assimilation with geostatistical analyses and pro-
vides information on exposure to PM2.5 at a 2× 2 km grid, which is a
much finer spatial scale than that provided by monitoring stations
(Bentayeb et al., 2014). This model was the best available model of air
pollution in France for the year 2005. Although the Gazel-Air model
coupled to neighbourhood-scale population density provides a fine
spatial resolution for a nationwide exposure assessment, it has been
suggested that models which do not take into account spatial contrasts
in exposure at a local (street) scale could underestimate the health
impact of air pollution (Morelli et al., 2016). Therefore, in this regard,
and also considering that our results confirm that further degrading the
spatial resolution of the air pollution model leads to lower PAF, our
estimates may be biased towards zero. New modelling techniques exist
at regional scales and allow a better characterization of the spatial
contrasts in the exposure to air pollution (Atmo Auvergne-Rhône-Alpes,
2015). Future studies may possibly rely on such improved models when
they become available at a national scale. The dose-response function is
based on findings from epidemiological studies. Most of them were
using fixed monitoring stations to assess PM2.5 levels. Finally, Bentayeb
et al. (2014) have shown that Gazel-Air model may underestimate
PM2.5 levels compared to monitoring stations, leading again to under-
estimating the PAF.
The PAF estimate strongly depends on other input data used for the
analysis. In particular, the choice of the PM2.5 concentration-response
function markedly influences the results (see the sensitivity analysis
H4). For the main analysis, we applied a RR from a meta-analysis by
Hamra et al. that was based on international studies (Hamra et al.,
2014). We used a robust RR with a low heterogeneity of the included
studies (I2= 53% with p=0.01). The meta-estimate combined
Fig. 2. Population-weighted exposures to PM2.5 estimated in France in 2005,
among adults aged 30 years or more. Estimates combine Gazel-Air model with
fine-scale population density data.
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incidence and mortality studies due to the high fatality rate among
incidence lung cancer cases. Most of the information was obtained from
cohort studies. The RR was based on 14 studies from mainly high in-
come countries in Europe, North America and Japan, but also one in
China. Some of these studies were adjusted for sex, smoking status and
socioeconomic position measured by income, education or occupation
(Hamra et al., 2014). Yet when comparing to other studies, our sensi-
tivity analyses call for careful examination of the assumptions on the
RR. The RR used for the sensitivity analysis was based on a meta-ana-
lysis of 14 cohorts from eight European countries adjusted for the fol-
lowing confounders: age, sex, calendar time, smoking status, smoking
intensity, square of smoking intensity, smoking duration, time since
quitting smoking, environmental tobacco smoke, occupation, fruit in-
take, marital status, education level, employment status and area-level
socioeconomic status (Raaschou-Nielsen et al., 2013). Advantage of this
RR is that it is based on standardized exposure assessment (land use
regression), includes only lung cancer incidence and was adjusted for a
large number of potential confounders. This study was included in the
meta-analysis by Hamra et al. (2014) contributing only by 1.2% to the
overall meta-estimate due to small population size.
Prevalence of tobacco smoking is still high in France, and corre-
sponded to 30% of the adult population in 2005, ten years before the
assessment of cancer incidence (Beck et al., 2007). Even though
smoking is the main risk factor for lung cancer, Turner et al. (2011)
have reported positive associations between mean long-term PM2.5
concentrations and lung cancer mortality in lifelong never-smokers,
suggesting that outdoor air pollution plays an important role in de-
velopment of lung cancer. However, given the strong relationship be-
tween cigarette smoking and lung cancer risk, a possible residual con-
founding by smoking could be of a concern if the RR applied in the PAF
estimation was not adjusted for smoking behaviour. The RR from the
meta-analysis used in the main model was based on 14 studies out of
which 11 adjusted for smoking status. By restricting the meta-analysis
only to the studies that adjusted for smoking as a confounder, the
overall RR was 1.10 (95%-CI: 1.04–1.17) instead of 1.09 (95%-CI:
1.04–1.14). The RR among never smokers was even higher (1.18; 95%-
CI: 1.00–1.39) (Hamra et al., 2014). This shows that if there is any
smoking-related confounding bias in the RR of lung cancer associated
with PM2.5 that we used, it leads to underestimation, and not
overestimation, of PM2.5 attributable fraction.
No information on national lung cancer incidence was available
with fine spatial distribution. We instead used lung cancer mortality
data by municipality to derive the PAF. As the prognosis of lung cancer
remains poor in France, with an overall 5-year survival of only about
15% (Cowppli-Bony et al., 2016), mortality level from lung cancer is
assumed to be similar to incidence. Finally, for data confidentiality
purposes, it was impossible to obtain mortality data at a finer scale than
the municipality. Even at this level, confidentiality reason prevents
dissemination of data in area where death counts were below 5 deaths.
Therefore, we had to impute the missing lung cancer deaths, which
however represented only 3% of the total number of lung cancer deaths
in France.
4.3. Interpretation
This study was unique in design since it utilised national data of
PM2.5 concentrations at a fine spatial scale in combination with lung
cancer data at the finest scale available, namely the municipality,
coupled to population distribution data at the neighbourhood level in
France. We estimated that about 1500 lung cancer cases were attribu-
table to PM2.5 exposure in France under the assumption that PM2.5
reference level is 10 μg/m3. This number of lung cancer cases represents
about 4% of all new lung cancer cases in France in 2015. A recent GBD
study provided PAF estimates for lung cancer deaths due to PM2.5 ap-
plying uniform distribution between 2.4 μg/m3 and 5.9 μg/m3 as re-
ference level of PM2.5 (GBD 2015 Risk Factors Collaborators, 2016). For
France, the GBD study estimated that about 2500 lung cancer deaths (or
7.4% of total) were due to ambient particulate matter pollution. The
results from the H3 sensitivity analysis may be compared to the GBD
study as the reference level of PM2.5 under this hypothesis was 4.9 μg/
m3 similar to the reference level applied in the GBD. Under this H3, we
estimated that 7.6% of lung cancer cases could be attributable to PM2.5
in France in 2015, a value very close to the GBD estimate for deaths. For
neighbouring countries, the fraction of lung cancer deaths attributable
to PM2.5 was estimated to be 9.4% in Belgium, 8.4% in Germany, 7.7%
in Switzerland, 11.6% in Italy, 5.6% in Spain, and 7.3% in the United
Kingdom (GBD 2015 Risk Factors Collaborators, 2016). A recent study
in Alberta, Canada, where air pollution levels are much lower than in
Table 1
Population attributable fraction (PAF) and number of lung cancer cases attributable to fine particulate matter (PM2.5) with the corresponding 95% confidence
intervals (95% CI), metropolitan France, ages 30 years and more, for the year 2015.
Hypothesis PM2.5 exposure:
5th–50th–95th percentiles
(μg/m3)
PAF (%) (95% CI) Number of attributable lung cancer cases (95% CI) Relative difference compared to main model (%)
Main model 8.2–13.8–21.8 3.6 (1.7–5.4) 1466 (679–2193) –
Sensitivity analyses
H1: median of population-weighted PM2.5 exposure
(a) Department 9.7–13.8–19.1 3.6 (1.7–5.4) 1471 (680–2203) 0.4
(b) Country 13.8–13.8–13.8 3.2 (1.5–4.9) 1303 (598–1965) −11.1
H2: median of raw PM2.5 concentration
(a) Department 6.0–11.1–16.4 2.4 (1.1–3.6) 964 (445–1446) −34.2
(b) Country 11.2–11.2–11.2 1.0 (0.5–1.6) 416 (190–631) −71.6
H3: alternative reference level for PM2.5 (4.9 μg/m3)
(a) Neighbourhood 8.2–13.8–21.8 7.6 (3.5–11.2) 3065 (1431–4550) 109.1
(b) Department 9.7–13.8–19.1 7.7 (3.6–11.5) 3120 (1455–4634) 112.8
(c) Country 13.8–13.8–13.8 7.4 (3.4–11.0) 2987 (1388–4453) 103.7
H4: alternative RR (1.40 per 10 μg/m3 increase in PM2.5)
(a) Neighbourhood 8.2–13.8–21.8 12.9 (0.2–25.3) 5232 (78–10,221) 256.8
(b) Department 9.7–13.8–19.1 13.1 (0.1–25.8) 5287 (27–10,429) 260.6
(c) Country 13.8–13.8–13.8 12.0 (0.0–25.0) 4855 (0–10,102) 231.1
H5: combination H3 and H4
(a) Neighbourhood 8.2–13.8–21.8 26.0 (0.0–47.9) 10,510 (2–19,360) 616.8
(b) Department 9.7–13.8–19.1 26.5 (0.0–49.1) 10,733 (0–19,845) 632.1
(c) Country 13.8–13.8–13.8 25.9 (0.0–49.0) 10,468 (0–19,813) 614.0
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France, estimated that about 2%–6% of incident lung cancer cases in
2012 may be attributable to PM2.5 exposure applying different re-
ference levels of PM2.5 (7.5 μg/m3 and 3.18 μg/m3, respectively)
(Poirier et al., 2017). Using the same reference level of PM2.5 (7.5 μg/
m3) as the Canadian study, 5.1% of lung cancer mortality was estimated
in South Africa in 2000 (Norman et al., 2007). The results of our sen-
sitivity analyses also show that, as expected, the PAF is larger when a
lower level of PM2.5 is set as the reference.
Commercial, institutional and household energy use and supply,
road transport, and industrial processes are the main contributors to
PM2.5 emissions in France accounting for about 90% of all PM2.5
emissions. To improve air quality in France, public policies should focus
on interventions reducing the emission from these particular sources
(European Environment Agency, 2014). International literature tends
to show that public policies and interventions can improve air quality
with consequently wide-ranging health benefits. Historically, introdu-
cing a ban on coal sales in Dublin in 1990 was reported to lead to an
immediate drop in black smoke (Clancy et al., 2002). The collapse of
industrial and agricultural structure in East Germany after German re-
unification in 1990 and the subsequent conversion from brown coal to
natural gas were associated with remarkable decreases in pollutant
emissions between 1989 and 1991 (Ebelt et al., 2001). A ban on re-
sidential wood burning in two urban areas of California in 2003 con-
tributed to a decline in PM2.5 concentrations in the range of 13%–14%
(Lighthall et al., 2009). Traffic related initiatives such as improvements
to bus networks and walking and cycling schemes in London in 2003
and in Stockholm in 2006 led to a decrease in PM10 concentrations of
0.8% (Tonne et al., 2008) and 7.6% (Johansson et al., 2009), respec-
tively.
The implementation of low emission zones, the improvement in
engine design and the installation of exhaust gas treatment systems
were shown to reduce PM2.5 concentrations in several cities worldwide.
For instance, after the introduction of low emission zones, PM2.5 con-
centrations were reduced by 5% in Copenhagen (Jensen et al., 2011)
and PM10 concentrations were reduced by about 10% in Munich
(Fensterer et al., 2014). PM2.5 concentrations were also positively cor-
related with traffic volumes and in particular with the volume of diesel
trucks. An ambitious traffic-related regulation policy in Tokyo led to a
decrease in PM2.5 concentration by 49.8% between 2001 and 2010
(Hara et al., 2013). Improvements in air quality were also reported
during the 1996 Summer Olympic Games in Atlanta (Friedman et al.,
2001) and in 2008 Summer Olympic Games in Beijing (Rich et al.,
2015). During the Olympic period, Atlanta experienced a 16% reduc-
tion in PM10 concentrations, attributed to traffic decline (Friedman
et al., 2001). As a condition for hosting the 2008 Olympic Games, the
Chinese government agreed to temporarily and substantially improve
air quality in Beijing for the Olympics by implementing heightened
vehicular emissions standards, by restricting use of vehicles by licence
plate number, by relocating and closing industrial facilities, and by
stopping construction activities (Zhang et al., 2013). These govern-
mental regulations resulted in a reduction by 27% in PM2.5 con-
centrations (Rich et al., 2012; Zhang et al., 2013).
Individual measurement of exposure to ambient PM2.5 is challen-
ging in large-scale studies. The projection of future health impacts of air
pollution may play an important role in policy discussion. However,
consistent methods for implementing such projections have not yet
emerged (Likhvar et al., 2015). In addition, studies based on cumulative
air pollution exposure over several years taking into account migration
and therefore accounting for different exposure to air pollution level
over life course will further improve the accuracy of health effects es-
timates related to the pollutants in the air. The chemical composition of
PM2.5 is diverse. Although factors and sources of PM more strongly
related to specific health outcomes has not been isolated yet (Adams
et al., 2015), some components and sources of PM may be more toxic
than others. The evaluation of the degree of toxicity for specific che-
mical components of PM2.5 is therefore essential for future assessments
of the impact of outdoor air pollution on the lung cancer incidence.
PM2.5 accounts only for a small part of air pollution mixture. Estimating
the effect of other pollutants than PM2.5 and/or the whole air pollution
mixture on lung cancer incidence should be priority in future etiologic
studies, so that these estimates can be incorporated in estimations of the
attributable fraction such as ours. Challenge for future HIAs is to better
understand and describe the uncertainties and public-health implica-
tions of the different choices made for the exposure modelling and
scenarios (Likhvar et al., 2015).
5. Conclusion
This study is the first nation-wide lung cancer risk assessment as-
sociated with outdoor PM2.5 exposure in France considering different
dose-response functions. Based on the main model, about 1500 lung
cancer cases (4% of total) could be attributed to PM2.5 yearly in France.
Depending on the risk models used, the total number of lung cancer
cases associated with PM2.5 exposure for the year 2015 ranged from 416
to 10,733. The calculations suggest that of the 40,451 lung cancer cases
in France that year, from 1.0% to 26.5% may be attributed to PM2.5
exposure. These results suggest that PM2.5 is one of the main con-
trollable causes of lung cancer in non-smokers. Policy action to reduce
PM2.5 concentrations in France has a large potential to reduce lung
cancer cases. Furthermore, improvements in the quality and spatial
coverage of the air pollution data and a deeper understanding of the air
pollution mixture are crucial for the investigation of future health im-
pacts. The PAF estimates and the number of attributable lung cancer
cases were highly sensitive to the choice of the concentration-response
function and the reference level of PM2.5. Taking into account popu-
lation distribution in future studies estimating the PAF is warranted due
to its high impact on the estimates.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2018.09.055.
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